Thomas H, Mullane M, Enkel S, McRae T, Amgarth-Duff I, Carapetis J
EClinicalMedicine. 2024; 77:102793.
PMID: 39649132
PMC: 11625017.
DOI: 10.1016/j.eclinm.2024.102793.
Cunningham N, Lamb J, Staller A, Krajden M, Hogg R, Towle A
Harm Reduct J. 2024; 21(1):75.
PMID: 38575970
PMC: 10996275.
DOI: 10.1186/s12954-024-00991-2.
Tam C, Wesseling T, Wang L, Salters K, Moore D, Dawydiuk N
BMC Public Health. 2023; 23(1):2524.
PMID: 38104090
PMC: 10725596.
DOI: 10.1186/s12889-023-17416-7.
Laniece Delaunay C, Klein M, Godin A, Cox J, Kronfli N, Lebouche B
Int J Drug Policy. 2023; 116:104026.
PMID: 37075626
PMC: 10080278.
DOI: 10.1016/j.drugpo.2023.104026.
Roth E, Cui Z, Armstrong H, Rich A, Lachowsky N, Sereda P
J Bisex. 2022; 21(3):405-423.
PMID: 35935471
PMC: 9355115.
DOI: 10.1080/15299716.2021.1982102.
Healthcare and treatment experiences among people diagnosed with HIV before and after a province-wide treatment as prevention initiative in British Columbia, Canada.
Tattersall T, Tam C, Moore D, Wesseling T, Grieve S, Wang L
BMC Public Health. 2022; 22(1):1022.
PMID: 35597938
PMC: 9123764.
DOI: 10.1186/s12889-022-13415-2.
A province-wide HIV initiative to accelerate initiation of treatment-as-prevention and virologic suppression in British Columbia, Canada: a population-based cohort study.
Nanditha N, Dong X, Tafessu H, Wang L, Lu M, Barrios R
CMAJ Open. 2022; 10(1):E27-E34.
PMID: 35042692
PMC: 8920539.
DOI: 10.9778/cmajo.20210093.
A Vulnerability Assessment for a Future HIV Outbreak Associated With Injection Drug Use in Illinois, 2017-2018.
Bergo C, Epstein J, Hoferka S, Kolak M, Pho M
Front Sociol. 2021; 6:652672.
PMID: 34095289
PMC: 8170011.
DOI: 10.3389/fsoc.2021.652672.
Implementation opportunities and challenges identified by key stakeholders in scaling up HIV Treatment as Prevention in British Columbia, Canada: a qualitative study.
Chayama K, McNeil R, Shoveller J, Small W, Knight R
Implement Sci Commun. 2020; 1:54.
PMID: 32885210
PMC: 7427937.
DOI: 10.1186/s43058-020-00044-2.
Development and Validation of a Risk Prediction Tool to Identify People with HIV Infection Likely Not to Achieve Viral Suppression.
Gebrezgi M, Fennie K, Sheehan D, Ibrahimou B, Jones S, Brock P
AIDS Patient Care STDS. 2020; 34(4):157-165.
PMID: 32324484
PMC: 7194316.
DOI: 10.1089/apc.2019.0224.
Developing a triage tool for use in identifying people living with HIV who are at risk for non-retention in HIV care.
Gebrezgi M, Fennie K, Sheehan D, Ibrahimou B, Jones S, Brock P
Int J STD AIDS. 2020; 31(3):244-253.
PMID: 32036751
PMC: 7044017.
DOI: 10.1177/0956462419893538.
Improving the UNAIDS 90-90-90 Treatment Targets: Solutions Suggested from a Qualitative Study of HIV Patients, Community Advocates, Health Workers and Program Managers in Jimma, Southwest Ethiopia.
Gesesew H, Ward P, Woldemichael K, Mwanri L
Int J Environ Res Public Health. 2020; 17(1).
PMID: 31935963
PMC: 6982005.
DOI: 10.3390/ijerph17010378.
Individual and neighborhood predictors of retention in care and viral suppression among Florida youth (aged 13-24) living with HIV in 2015.
Gebrezgi M, Sheehan D, Mauck D, Fennie K, Ibanez G, Spencer E
Int J STD AIDS. 2019; 30(11):1095-1104.
PMID: 31551004
PMC: 7089851.
DOI: 10.1177/0956462419857302.
Randomised controlled trial conducted in injecting equipment provision sites to compare the effectiveness of different hepatitis C treatment regimens in people who inject drugs: A Direct obserVed therApy versus fortNightly CollEction study for HCV....
Inglis S, Beer L, Byrne C, Malaguti A, Robinson E, Sharkey C
BMJ Open. 2019; 9(8):e029516.
PMID: 31399460
PMC: 6701606.
DOI: 10.1136/bmjopen-2019-029516.
"Condoms are … like public transit. It's something you want everyone else to take": Perceptions and use of condoms among HIV negative gay men in Vancouver, Canada in the era of biomedical and seroadaptive prevention.
Klassen B, Fulcher K, Chown S, Armstrong H, Hogg R, Moore D
BMC Public Health. 2019; 19(1):120.
PMID: 30691426
PMC: 6350294.
DOI: 10.1186/s12889-019-6452-7.
Viral suppression and viral rebound among young adults living with HIV in Canada.
Palmer A, Gabler K, Rachlis B, Ding E, Chia J, Bacani N
Medicine (Baltimore). 2018; 97(22):e10562.
PMID: 29851775
PMC: 6392935.
DOI: 10.1097/MD.0000000000010562.
Prevalence of Primary Drug Resistance Against HIV-1 Integrase Inhibitors in Canada.
Ji H, Patterson A, Taylor T, Rank C, Halverson J, Capina R
J Acquir Immune Defic Syndr. 2018; 78(1):e1-e3.
PMID: 29424788
PMC: 5902129.
DOI: 10.1097/QAI.0000000000001649.
A historical review of HIV prevention and care initiatives in British Columbia, Canada: 1996-2015.
Olding M, Enns B, Panagiotoglou D, Shoveller J, Harrigan P, Barrios R
J Int AIDS Soc. 2017; 20(1):21941.
PMID: 28953322
PMC: 5640311.
DOI: 10.7448/IAS.20.1.21941.
Gay Men's Understanding and Education of New HIV Prevention Technologies in Vancouver, Canada.
Klassen B, Lachowsky N, Lin S, Edward J, Chown S, Hogg R
Qual Health Res. 2017; 27(12):1775-1791.
PMID: 28936925
PMC: 5664952.
DOI: 10.1177/1049732317716419.
Long-Acting Injectable Antiretroviral Therapy: An Opportunity to Improve Human Immunodeficiency Virus (HIV) Treatment and Reduce HIV Transmission Among Persons Being Released From Prison Facilities.
Brinkley-Rubinstein L, Rosen D, Christopher P, Bazerman L, Beckwith C
Clin Infect Dis. 2017; 65(7):1247-1248.
PMID: 28549121
PMC: 5849091.
DOI: 10.1093/cid/cix493.
